Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...
Discontinuation of RAAS inhibitors is often the first approach to manage hyperkalemia. Discontinuation of renin–angiotensin-aldosterone system (RAAS) inhibitors after the first hyperkalemia episode ...
At one time, dual RAAS blockade was expected to provide more-complete inhibition of RAAS among patients with DKD. Results of large clinical trials dashed these hopes, finding increased risk of AKI and ...
Renin–angiotensin–aldosterone system (RAAS) blockade using angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers, which have antihypertensive and antialbuminuric properties, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback